申请人:Vanotti Ermes
公开号:US20100075998A1
公开(公告)日:2010-03-25
The present invention provides tricyclic indoles and (4,5-dihydro) indoles of the formula (I) or a pharmaceutically acceptable salt thereof: wherein the ring A represents a fused pyrazole, pyridine or pyrimidine,
means either simple or double carbon-carbon bond and R
1
, R
2
and R
3
are as defined in the specification. Further objects of the invention are a process for the preparation of the compounds of the formula (I), pharmaceutical compositions comprising them and methods for treating cell proliferative disorders. As a matter of fact, the compounds of the formula (I) are useful, in therapy, in the treatment of diseases associated with a disregulated protein kinase activity, in particular Cdc7 and AKT kinase activity, like cancer.
本发明提供了三环吲哚和(4,5-二氢)吲哚的公式(I)或其药学上可接受的盐:其中环A代表融合的吡唑、吡啶或嘧啶,表示单重或双重碳-碳键,R1、R2和R3如规范中所定义。本发明的进一步目标是公式(I)化合物的制备方法,包含它们的制药组合物以及治疗细胞增殖性疾病的方法。事实上,公式(I)化合物在治疗与失调的蛋白激酶活性有关的疾病,特别是Cdc7和AKT激酶活性,如癌症方面非常有用。